Bruker to Host Investor Day on June 20th, 2019

Date : 06/14/2019 @ 11:00AM
Source : PR Newswire (US)
Stock : Bruker Corporation (BRKR)
Quote : 50.7103  0.7603 (1.52%) @ 3:31PM

Bruker to Host Investor Day on June 20th, 2019

Historical Stock Chart

6 Months : From Jun 2019 to Dec 2019

Click Here for more Bruker Charts.

BILLERICA, Mass., June 14, 2019 PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) will host an Investor Day on June 20th, 2019, starting at 8:00 AM Eastern Time, at the Nasdaq MarketSite, 4 Times Square in New York City.

Bruker Corporation Logo

The Bruker Investor Day will feature business, management process, operational excellence and strategy updates. Moreover, Bruker's executive leadership team will provide greater details on its key Project Accelerate™ high-growth and high-margin initiatives.

Bruker will also communicate its expectations for future financial performance on organic revenue growth, operating margin expansion and earnings growth. Analysts and investors will have opportunities for discussions in two Q&A sessions with CEO Frank Laukien and senior members of Bruker's executive leadership team.

In-person attendance at the event is by invitation and registration only. The Investor Day presentation will be broadcast live, beginning at 8:00 am EDT. It can be accessed via the company's Investor Relations website at Bruker Investor Day. A replay of the webcast will also be available.

About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

For more information: 


Pam Clark
Investor Relations
Bruker Corporation 
T: +1 (978) 663 – 3660, ext.1479 

Cision View original content to download multimedia:

SOURCE Bruker Corporation

Copyright 2019 PR Newswire

Latest BRKR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.